LONDON, August 19, 2019 – George Clinical, a global scientifically-backed clinical research organization (CRO), has expanded its presence in Europe with the opening of a larger and more sophisticated location in the United Kingdom. The office is based in London and compliments the organization’s growing list of global locations throughout the Asia-Pacific region, the United […]
Read MoreIn what could come as a big boost to entrepreneurs working to promote healthcare through innovations across the globe, University of New South Wales—Sydney and The George Institute for Global Health (TGI) have joined forces to launch a program dubbed Health10x designed to accelerate and scale up health focused start-ups. The Health10x program was conceived […]
Read More
George Clinical is pleased to announce that Dr. Bruce Neal has been appointed Executive Director of The George Institute Australia effective September 1. Neal was a founding member of the Institute, together with John Chalmers and Principal Directors Stephen MacMahon and Robyn Norton. Neal has contributed to the growth of the Institute across many areas […]
Read MoreGeorge Clinical welcomes the addition of fixed dose combinations (FDCs) of blood pressure (BP) lowering drugs to the World Health Organization (WHO) Essential Medicines List (EML) in response to an application filed by Resolve to Save Lives (RTSL), an initiative of vital strategies, The George Institute and other partners. Adding FDCs of blood pressure lowering […]
Read MoreA global study of 12 million people has found diabetes increases the risk of heart failure and this increase is greater for women than men. Researchers from The George Institute for Global Health determined that this differential was greater in Type 1 than Type 2 diabetes. Type 1 diabetes is associated with a 47% excess […]
Read MoreThe Indian subcontinent deserves to be considered by pharmaceutical or biotech firms examining clinical trial locations, and veteran industry players may be surprised to learn India is already a leading destination for global clinical trials with significant growth taking place in the biotech sector. Prime opportunities exist for all phases of clinical trials due to […]
Read MoreLast year George Clinical gained recognition by the Mandatory Provident Fund (MPF) legislation for their provision of good MPF benefits in Hong Kong. The Mandatory Provident Fund Schemes Authority (MPFA) awarded George Clinical their Good MPF Employer Award at a ceremony in Hong Kong where Evon Hui, Head of Business Operations, East Asia, accepted the […]
Read MoreSYDNEY, June 17, 2019 – George Clinical, a global scientifically driven CRO, today announced the appointment of Meelian Hoh to the role of Chief Financial Officer. With extensive financial management experience spanning more than 20 years, Hoh brings leadership in financial accountability, enterprise system implementation and pharma industry market knowledge to the George Clinical executive […]
Read MoreDecember of 2018 saw the FDA release their “Framework For Evaluating the Potential Use of Real-World Evidence (RWE)” to support the approval of a new indication for a drug already approved under section 505(c) of the FD&C Act. This document was developed to outline guidance and support of real world data collection efforts for post-approval […]
Read MoreGeorge Clinical is proud to have been involved in developing the recently announced recommendations by the Clinical Trial Transformation Initiative (CTTI): The Recommendations for Engaging Patients and Sites in Mobile Clinical Trials. The recommendations, to which George Clinical contributed as a member on the expert committee, aim to help research organizations, sponsors, and other stakeholders […]
Read More
